Internal Medicine, Rheumatology · Rochester, NY
NPI
1053923441
Since 2020
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
125 Lattimore Rd, Suite G-110
Rochester, NY, 14620
Phone (585) 486-0901
Groups this clinician bills Medicare through
Medicare paid, 2024
$12K
322 services
Medicare patients, 2024
127
Average age 68
Drug cost, 2024
$5.4M
1,773 prescriptions
Company payments, 2025
$6,118
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Norman Madsen was code 99214 (office e&m - established), 137 times for 85 patients. In total Norman Madsen billed 322 services in 12 codes, and Medicare paid $12K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-08-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 137 | 85 | $60.88 | $8,341 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 110 | 70 | $11.05 | $1,216 |
| 76881 Ultrasound - Nonspecific | Office | 51 | 28 | $30.80 | $1,571 |
By year: 2022 $16K for 296 services; 2023 $14K for 263 services; 2024 $12K for 322 services.
Medicare prescription drug claims, 2024
In 2024, the drug Norman Madsen prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 251 prescriptions and refills. In total Norman Madsen wrote 1,773 Medicare prescriptions that cost $5.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 251 | 678 | 83 | $8,350 |
| Hydroxychloroquine Sulfate Generic | 199 | 500 | 57 | $8,354 |
| Prednisone Generic | 149 | 254 | 67 | $1,267 |
| Taltz Autoinjector Ixekizumab | 90 | 92 | 12 | $608K |
| Humira(Cf) Pen Adalimumab | 89 | 95 | 12 | $776K |
| Enbrel Sureclick Etanercept | 69 | 77 | Under 11 | $547K |
| Allopurinol Generic | 68 | 188 | 16 | $811 |
| Enbrel Etanercept | 55 | 56 | Under 11 | $390K |
| Kevzara Sarilumab | 49 | 60 | Under 11 | $253K |
| Celecoxib Generic | 48 | 80 | 19 | $1,108 |
| Leflunomide Generic | 46 | 111 | 13 | $2,511 |
| Folic Acid Generic | 43 | 128 | 16 | $415 |
| Cimzia (2 Pack) Certolizumab Pegol | 41 | 41 | Under 11 | $228K |
| Cosentyx Sensoready (2 Pens) Secukinumab | 40 | 49 | Under 11 | $326K |
| Humira(Cf) Adalimumab | 27 | 27 | Under 11 | $164K |
Brand drugs: - claims; generic drugs: 1,021 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Norman Madsen $6,118 ($6,118 in general payments such as food, travel and fees) from 3 companies. The largest payer was Eli Lilly and Company with $5,850.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.